IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 233 filers reported holding IMMUNOVANT INC in Q4 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $630 | -55.6% | 23,855 | -45.7% | 0.00% | -50.0% |
Q1 2024 | $1,420 | -13.4% | 43,936 | +12.9% | 0.00% | 0.0% |
Q4 2023 | $1,640 | +42.9% | 38,931 | +30.2% | 0.00% | 0.0% |
Q3 2023 | $1,148 | +182.1% | 29,911 | +39.5% | 0.00% | +100.0% |
Q2 2023 | $407 | +20.1% | 21,441 | -2.0% | 0.00% | – |
Q1 2023 | $339 | -23.8% | 21,889 | -12.6% | 0.00% | -100.0% |
Q4 2022 | $445 | -99.7% | 25,043 | -0.1% | 0.00% | – |
Q3 2022 | $140,000 | +44.3% | 25,056 | +0.3% | 0.00% | – |
Q2 2022 | $97,000 | -29.7% | 24,989 | -0.2% | 0.00% | – |
Q1 2022 | $138,000 | -35.2% | 25,031 | 0.0% | 0.00% | – |
Q4 2021 | $213,000 | -2.3% | 25,031 | -0.3% | 0.00% | – |
Q3 2021 | $218,000 | -17.4% | 25,095 | +0.4% | 0.00% | – |
Q2 2021 | $264,000 | -51.3% | 25,003 | -26.0% | 0.00% | -100.0% |
Q1 2021 | $542,000 | -65.3% | 33,800 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $1,561,000 | +40.4% | 33,800 | +7.0% | 0.00% | +100.0% |
Q3 2020 | $1,112,000 | +161.0% | 31,600 | +80.6% | 0.00% | 0.0% |
Q2 2020 | $426,000 | – | 17,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alpine Global Management, LLC | 3,000,200 | $26,072,000 | 5.92% |
MANGROVE PARTNERS IM, LLC | 1,139,900 | $9,906,000 | 0.89% |
Eventide Asset Management | 4,950,000 | $43,016,000 | 0.57% |
Ghost Tree Capital, LLC | 200,000 | $1,738,000 | 0.51% |
WITTENBERG INVESTMENT MANAGEMENT, INC. | 140,500 | $1,221,000 | 0.47% |
FRAZIER MANAGEMENT LLC | 585,759 | $5,090,000 | 0.41% |
MANGROVE PARTNERS IM, LLC | 500,000 | $4,345,000 | 0.39% |
EcoR1 Capital, LLC | 1,140,819 | $9,914,000 | 0.34% |
BCK CAPITAL MANAGEMENT LP | 53,459 | $465,000 | 0.28% |
PLATINUM INVESTMENT MANAGEMENT LTD | 555,065 | $4,824,000 | 0.14% |